Clinical Trial Update: An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA) [Phase 1, Phase 2]

View source ↗

Summary

Opti-GAIN is a Phase 1/2 interventional trial evaluating the safety and potential efficacy of CTx001 for Geographic Atrophy due to age-related macular degenerat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• CTX001

Snippet

Sponsor: Complement Therapeutics | Conditions: Geographic Atrophy Secondary to Age-related Macular Degeneration | Phase 1, Phase 2 | Status: RECRUITING